… corticosteroids. This study suggested that asthmatic patients treated with high-dose inhaled
BDP and intermittent systemic corticosteroids experienced a reduction in vertebral bone …

… Asthma is a common inflammatory airway disease for which the most commonly used
controller medications are inhaled corticosteroids (ICS). Asthma control is difficult to achieve in …

… features of asthma. Inhaled corticosteroids have revolutionized asthma management and
have now become the mainstay of therapy for patients with persistent asthma. There has …

… and related symptoms, regardless of the severity of asthma [2]. Inhaled corticosteroids (ICS)
are the treatment of choice for long-term asthma control in both adults and children [3]. Long-…

… cumulative dose of inhaled corticosteroid and bone-mineral density in patients with asthma.
… One in three asthmatic patients in the UK takes an inhaled corticosteroid regularly, and a …

… primary nonadherence to inhaled corticosteroids (ICSs) in an urban setting among a large
population of patients with asthma. We also examined patient characteristics associated with …

… risk of pneumonia in patients with asthma using inhaled corticosteroids. Inhaled corticosteroids
(ICS) are the mainstay of treatment for all symptomatic patients with asthma (1, 2). ICS …

… have an effect on the effectiveness of inhaled corticosteroid (ICS) treatment by conducting a
… patient compliance with inhaled asthma therapy. Second, we examined inhalation technique…

… exacerbations is a primary management goal for asthma across the severity spectrum.
Inhaled corticosteroids (ICSs) decrease the risk of asthma exacerbations, but patient adherence …

… start treatment with inhaled corticosteroids in all patients with asthma with use of inhaled
bronchodilators of more than three doses a week, and/or regular asthma symptoms during day …